Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials

BACKGROUND: Erythropoiesis-stimulating agents (ESAs) are the standard treatment for patients with renal anemia to increase hemoglobin (Hb) levels and reduce the need for blood transfusions. However, treatments targeting high Hb levels require high doses of ESAs administered intravenously, which is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Hiroyasu, Yamada, Takashi, Miyazaki, Ken, Yamashita, Takuto, Kato, Takuya, Ohara, Kenichi, Nakamura, Yusuke, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352152/
https://www.ncbi.nlm.nih.gov/pubmed/37095342
http://dx.doi.org/10.1007/s10157-023-02353-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352152/
https://www.ncbi.nlm.nih.gov/pubmed/37095342
http://dx.doi.org/10.1007/s10157-023-02353-x

Ejemplares similares